期刊文献+

CD4^+T细胞在抗肿瘤过继性免疫治疗中作用的研究 被引量:7

The Studies on Distribution of Th1/Th2 Subsets in Purified CD4^+T Cells from CIKs
在线阅读 下载PDF
导出
摘要 目的:观察CIK细胞中CD4+T细胞中Th1/Th2亚群分布情况。方法:体外大规模扩增CIK细胞,磁珠法纯化其中CD4+T细胞。采用胞内染色、ELISA和荧光定量RT-PCR法检测培养前后Th1/Th2细胞亚群的比例、Th1/Th2类细胞因子的分泌量和基因表达的变化。结果:富集CD4+细胞纯度达96%,CIK中Th1亚群和Th0亚群的比例较PBMC显著升高(P<0.05),而Th2亚群无显著变化。CD4+CIK细胞中IL-2和IFN-γ等Th1类细胞因子释放量增高(P<0.01),而IL-10和TGF-"等Th2类细胞因子释放量降低(P<0.05)。但CD4+CIK细胞中除IFN-γ的mRNA显著升高外(P<0.05),IL-2和IL-4的mRNA变化不明显。结论:CIK细胞中的CD4+T细胞具有明显的Th1优势。 Objective: To observe the distribution of Th1/Th2 subsets in CD4^+T cells of cytokineinduced killer (CIKs). Methods: After large scale of amplification of CIKs, CD4^+T cells subset was isolated by magnetic beads separation columns, and the proportion of IFN-γand IL-4 secreting cells were analyzed by intracellular cytokine staining. The cytokines of Th1 kind and Th2 kind, released by purified CD4^+T ceils from the CIKs or PBMCs, were detected by ELISA and fluorescent real-time quantitive RT-PCR methods. Results: Purity of enriched CD4^+T cells reached 96%. Comparing with PBMCs, a significant increase (P〈0.05) in Thl subset (IFN-γ^+ IL-4^- cells) and Th0 subset (IFN-γ^+ IL-4^+ cells) was respectively observed while no statistical change (P〉0.05) was found in Th2 subset(IFN-γ^- IL-4^+ cells)in CD4^+ CIKs. Secretion of Th1 kind of cytokines, such as IL-2 and IFN-γ in CD4^+T cells of CIKs enhanced significantly, and Th2 kind of cytokines, such as IL-10 and TGF-β decreased obviously (P〈0.05). Except for IFN-γ no increase in mRNA synthesis of IL-2 or IL-4 was observed in CD4^=+T cells in CIKs compared to PBMCs. Conclusion: This study indicates that a distinct “Th1 dominance” exists in CD4^+T cells of CIKs.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2005年第14期795-797,共3页 Chinese Journal of Clinical Oncology
基金 天津市科委自然科学基金资助(编号:023611011)
关键词 CIK细胞 CD4^+T细胞亚群 Th1优势 CIK CD4^+T cells subset Th1 dominance
  • 相关文献

参考文献2

二级参考文献4

共引文献35

同被引文献77

  • 1任秀宝,于津浦,刘虹,张澎,郝希山.磁珠分选系统和胞内染色法联合分析细胞因子诱导杀伤细胞中Th1/Th2细胞亚群分布特点[J].中华检验医学杂志,2005,28(5):486-488. 被引量:6
  • 2应敏刚,郑秋红,陈奕贵,谢云青,龚福生,陈路川,吴君心,郑天荣.CIK与DC细胞联合治疗145例晚期恶性实体瘤[J].福建医科大学学报,2007,41(3):218-221. 被引量:19
  • 3[2]Kayagaki N,Yamaguchi N,Nakayama M et al.Involvement of TNF-related apoptosis-inducing ligand in human CD4+T cell-mediated cytotoxicity[J].J Immunol,1999;162 (5):2639-2647.
  • 4[3]Von Reyher U,Strater J,Kittstein W et al.Colon carcinoma cells use different mechanisms to escape CD 95-mediated apoptosis[J] Cancer Res,1998;58 (2):526-534.
  • 5[4]Airoldi I,Lualdi S,Bruno S et al.Expression of costimulatory molecules in human neuroblastoma evidence that CD40+ neuroblastoma cells undergo apoptosis following interaction with CD40L[J].Br J Cancer,2003 ;88 (10):1527-1536.
  • 6[5]Lee J K,Seki N,Sayers T J et al.Constitutive expression of functional CD40 on mouse renal cancer cells:induction of Fas and Fasmediated killing by CD40L[J].Cellular Immunology,2005; 235(2):145-152.
  • 7[6]Messmer D,Kipps T J.CD154 gene therapy for human B-cell malignancies[J].Ann N Y Acad Sci,2005;1062:51-60.
  • 8[7]Kater A P,Dicker F,Mangiola M et al.Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis[J].Blood,2005;106(5):1742-1748.
  • 9[8]Wischhusen J,Schneider D,Mittelbronn M et al.Death receptor-mediated apoptosis in human malignant glioma cells:modulation by the CD40/CD40L system[J].J Neuroimmunol,2005; 162(1-2):28-42.
  • 10[9]Dicker F,Arnon P Kater,Tetsuya Fukuda et al.Fas-ligand (CD178)and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells[J].Blood,2005; 105 (8):3193 -3198.

引证文献7

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部